These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 6489420)

  • 1. Bioavailability and pharmacokinetics of phenytoin during pregnancy.
    Lander CM; Smith MT; Chalk JB; de Wytt C; Symoniw P; Livingstone I; Eadie MJ
    Eur J Clin Pharmacol; 1984; 27(1):105-10. PubMed ID: 6489420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of bioavailability on the calculated Michaelis-Menten parameters of phenytoin in children.
    Koren G; Brand N; MacLeod SM
    Ther Drug Monit; 1984; 6(1):11-4. PubMed ID: 6710554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hematologic effects of phenytoin therapy during pregnancy.
    Strauss RG; Ramsay RE; Willmore LJ; Wilder BJ
    Obstet Gynecol; 1978 Jun; 51(6):682-5. PubMed ID: 662246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of pregnancy on antiepileptic drug utilization.
    Levy RH; Yerby MS
    Epilepsia; 1985; 26 Suppl 1():S52-7. PubMed ID: 3922750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenytoin kinetics during pregnancy and the puerperium.
    Knott C; Williams CP; Reynolds F
    Br J Obstet Gynaecol; 1986 Oct; 93(10):1030-7. PubMed ID: 3790462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenytoin metabolism in pregnancy.
    Kochenour NK; Emery MG; Sawchuk RJ
    Obstet Gynecol; 1980 Nov; 56(5):577-82. PubMed ID: 7432728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epilepsy and pregnancy. Serum thyroxine levels during phenytoin therapy.
    Strauss RG; Ramsay RE; Willmore LJ; Spellacy WN; Wilder BJ
    Obstet Gynecol; 1979 Mar; 53(3):344-7. PubMed ID: 424107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Status epilepticus in pregnancy: effect of phenytoin malabsorption on seizure control.
    Ramsay RE; Strauss RG; Wilder BJ; Willmore LJ
    Neurology; 1978 Jan; 28(1):85-9. PubMed ID: 563542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma anticonvulsant concentrations during pregnancy.
    Lander CM; Edwards VE; Eadie MJ; Tyrer JH
    Neurology; 1977 Feb; 27(2):128-31. PubMed ID: 556828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of pregnancy on various pathways of human antiepileptic drug metabolism.
    Bernus I; Hooper WD; Dickinson RG; Eadie MJ
    Clin Neuropharmacol; 1997 Feb; 20(1):13-21. PubMed ID: 9037569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism of diphenylhydantoin (phenytoin) during pregnancy.
    Landon MJ; Kirkley M
    Br J Obstet Gynaecol; 1979 Feb; 86(2):125-32. PubMed ID: 427051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of increased bioavailability of phenytoin tablets on serum phenytoin concentration in epileptic out-patients.
    Neuvonen PJ; Bardy A; Lehtovaara R
    Br J Clin Pharmacol; 1979 Jul; 8(1):37-41. PubMed ID: 552295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical pharmacokinetics of phenytoin.
    Richens A
    Clin Pharmacokinet; 1979; 4(3):153-69. PubMed ID: 383353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of the bioavailability of Polfa phenytoin tablets].
    Lazowski J; Lypka A; Zadrozyńska E; Pakszys W
    Neurol Neurochir Pol; 1978; 12(3):251-5. PubMed ID: 683430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic failures in epileptic children due to impaired diphenylhydantoin bioavailability.
    Koren G; Brand N; Daney S; Halkin H
    Isr J Med Sci; 1982 Jun; 18(6):721-3. PubMed ID: 7107212
    [No Abstract]   [Full Text] [Related]  

  • 16. Phenytoin: pharmacokinetics and bioavailability.
    Gugler R; Manion CV; Azarnoff DL
    Clin Pharmacol Ther; 1976 Feb; 19(2):135-42. PubMed ID: 1261151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioavailability and single-dose pharmacokinetics of intramuscular phenytoin.
    Kostenbauder HB; Rapp RP; McGovren JP; Foster TS; Perrier DG; Blacker HM; Hulon WC; Kinkel AW
    Clin Pharmacol Ther; 1975 Oct; 18(4):449-56. PubMed ID: 1100308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical pharmacokinetics of phenytoin in the dog: a reevaluation.
    Frey HH; Löscher W
    Am J Vet Res; 1980 Oct; 41(10):1635-8. PubMed ID: 6784613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antipyrine disposition in relation to lowered anticonvulsant plasma level during pregnancy.
    Chiba K; Ishizaki T; Tabuchi T; Wagatsuma T; Nakazawa Y
    Obstet Gynecol; 1982 Nov; 60(5):620-6. PubMed ID: 6815599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenytoin impairs the bioavailability of dexamethasone in neurological and neurosurgical patients.
    Chalk JB; Ridgeway K; Brophy T; Yelland JD; Eadie MJ
    J Neurol Neurosurg Psychiatry; 1984 Oct; 47(10):1087-90. PubMed ID: 6502166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.